pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 2·1 min read
save

Telemedicine surge could eliminate traditional doctor’s office waiting rooms

Jun 2, 2026·read at STAT ↗Positive

Emergency physician Iyesatta Massaquoi Emeli reflects on how the concept of waiting has been built into medical practice, from the lobby to the triage process, shaping patients' experience of care.

The COVID‑19 pandemic rapidly lifted long‑standing policy and regulatory obstacles to remote consultations, sparking a massive growth in virtual care. This shift prompted a reassessment of which patients truly need to be seen in person.

Emeli argues that the health system should now redesign how patients enter care, using technology to reduce delays rather than accepting waiting as inevitable.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: The virtual end of the doctor’s office waiting room”

read at STAT ↗
1,334 words · retrieved Jun 2
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Emory University2
topics
GLP-1 receptorHematology

related stories

  • Jul 18Opinion: STAT readers on the value of primary care, obesity as a disease, and moreSTAT
  • Jul 16Opinion: The growing fang-to-pharmacy pipelineSTAT
  • Jul 15STAT+: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and moreSTAT
  • Jul 14STAT+: Pharmalittle: We’re reading about a battle between Lilly and Teva, psychedelic drugs, and moreSTAT
  • Jul 7Kailera says obesity pill succeeds in late-stage trial in ChinaBioPharma Dive